Clinical research company Medpace Holdings (NASDAQ:MEDP) in Q4 CY2024, with sales up 7.7% year on year to $536.6 million. On ...
Madison Investments, an investment advisor, released its “Madison Small Cap Fund” fourth-quarter 2024 investor letter. A copy ...
Q4 2024 Earnings Call Transcript February 11, 2025 Operator: And good day, ladies and gentlemen, and welcome to the Medpace ...
Clinical research company Medpace Holdings (NASDAQ:MEDP) will be announcing earnings results tomorrow after market hours.
LOS ANGELES, CA / ACCESS Newswire / February 18, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...
Rhumbline Advisers lifted its position in Medpace Holdings, Inc. (NASDAQ:MEDP – Free Report) by 0.8% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional ...
Hosted on MSN10d
Why Medpace (MEDP) Shares Are Trading Lower TodayWhat Happened? Shares of clinical research company Medpace Holdings (NASDAQ:MEDP) fell 8.7% in the pre-market session after ...
Earnings Call Insights: Medpace Holdings, Inc. (NASDAQ:MEDP) Q4 2024 CEO August Troendle noted that backlog cancellations in Q4 were within the normal range, with a book-to-bill ratio of 0.99 due to ...
Equities research analysts at William Blair decreased their Q3 2025 earnings estimates for Medpace in a research report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results